For Doctors in a Hurry
- Researchers investigated whether mild to moderate acute kidney injury independently alters long term kidney function trajectories after accounting for pre-existing patient differences.
- This study utilized linear mixed-effects regression models to analyze 1,603 participants within the ASSESS-AKI cohort over a multiyear follow up period.
- Acute kidney injury was associated with a small non-recovery to baseline of -1.32 ml/min per 1.73 m² (95% CI, -2.19 to -0.45).
- The authors concluded that the independent association between mild kidney injury and subsequent worsening kidney function is of small magnitude.
- These findings suggest that the clinical importance of mild acute kidney injury as a driver of chronic kidney disease is likely limited.
Reassessing the Long-Term Impact of Acute Renal Insults
Chronic kidney disease affects approximately 13.4% of the global population and remains a major driver of cardiovascular morbidity and mortality [1]. Acute kidney injury is a frequent complication in hospitalized patients, particularly those with comorbid hypertension, heart failure, or sepsis [2]. While clinical guidelines emphasize the importance of implementing protective strategies to reduce the frequency and severity of these acute events [3], the long-term impact of mild to moderate injury on a patient's functional trajectory remains a subject of intense debate. This is especially relevant as newer therapies, such as sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists, are increasingly used to manage renal and cardiovascular risks in these complex populations [4, 5]. A recent analysis now clarifies the independent contribution of acute injury to long-term kidney function decline, revealing that mild insults may not alter long-term disease trajectories as much as previously feared.
Rigorous Control for Pre-Existing Renal Health
To address the limitations of previous research, investigators from the ASsessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) study focused on a critical methodological gap. Prior studies have not adequately controlled for pre-existing differences between patients who did or did not develop acute kidney injury. This lack of control often makes it difficult for clinicians to determine if a decline in renal function is a direct consequence of the acute insult or merely a continuation of a patient's pre-existing disease course. To resolve this, the researchers utilized linear mixed-effects regression models (a statistical method that tracks individual changes over time while accounting for baseline differences). This approach allowed the team to isolate the specific impact of the acute event from the patient's underlying health status.
The study included a robust cohort of 1,603 participants. To ensure a precise measurement of renal performance, the researchers estimated the glomerular filtration rate using two distinct biomarkers: serum creatinine (eGFRcr) and cystatin C (eGFRcys). By employing both markers, the study provided a more comprehensive assessment of filtration capacity than creatinine alone, which can be influenced by muscle mass and diet. This rigorous framework enabled the investigators to analyze how an episode of mild to moderate injury independently influenced the long-term trajectory of kidney function after accounting for pre-existing proteinuria and baseline filtration rates.
The findings challenge the historical assumption that acute kidney injury is a limited and entirely reversible condition, demonstrating instead that even less severe insults result in a measurable, permanent deficit in renal performance. The study specifically focused on mild to moderate episodes of acute kidney injury. Among the participants who developed the condition, 83.1% of cases were classified as Kidney Disease: Improving Global Outcomes (KDIGO) Stage 1, while 12.2% were classified as KDIGO Stage 2. By analyzing these specific stages, which represent mild to moderate elevations in serum creatinine or transient reductions in urine output, the authors provided a granular view of how common clinical presentations of renal stress impact long-term physiology.
In a fully adjusted analysis, the researchers found that mild to moderate acute kidney injury was independently associated with a small magnitude loss of kidney function, defined as a failure to return to the patient's original baseline. This permanent drop was consistent across different biomarkers of filtration. For the estimated glomerular filtration rate calculated using serum creatinine, the independent loss of function was -1.32 ml/min per 1.73 m2 (95% confidence interval [CI], -2.19 to -0.45). When the researchers used cystatin C, the loss was -1.59 ml/min per 1.73 m2 (95% CI, -2.44 to -0.74). These data points quantify the immediate functional cost of an acute injury. They suggest that while the insult may resolve clinically, it leaves a small but measurable scar on the kidney's total filtration capacity.
Stability of Post-Injury Filtration Slopes
Beyond the initial drop in filtration capacity, a critical clinical concern for physicians is whether an acute kidney injury event alters the long-term trajectory of renal health by accelerating the annual rate of decline. The researchers addressed this by examining the estimated glomerular filtration rate slope, which represents the yearly change in filtration capacity. Their analysis demonstrated that there were no statistically significant changes in the eGFR slope following an episode of acute kidney injury. This finding suggests that while the initial insult causes a discrete, permanent loss of function, it does not trigger a progressive or faster deterioration of the kidneys over time.
To ensure the robustness of these findings, the authors calculated the slope using two distinct markers of renal function. When using serum creatinine to estimate the filtration rate, the change in the eGFRcr slope after the acute kidney injury was -0.23 ml/min per 1.73 m2 per year (95% CI, -0.73 to 0.26). Similarly, when the researchers utilized cystatin C, the change in the eGFRcys slope was -0.25 ml/min per 1.73 m2 per year (95% CI, -0.74 to 0.23). Because both confidence intervals crossed zero, the data indicate that the rate of kidney function decline remained stable relative to the patient's pre-injury trajectory. For the clinician, these results imply that the primary long-term risk of mild to moderate acute kidney injury is the immediate, non-recoverable loss of nephron mass rather than a fundamental change in the underlying pace of chronic kidney disease progression.
Clinical Significance and Prognostic Priorities
The researchers utilized a rigorous statistical framework to isolate the specific impact of the acute event from the baseline health of the 1,603 participants. This analysis specifically accounted for the pre-injury eGFR slope, which represents the patient's rate of kidney function decline prior to the injury, as well as pre-injury proteinuria, a well-established marker of existing renal damage. By adjusting for these variables and other potential confounders, the study sought to determine whether the acute insult independently accelerated decline or if post-injury function simply reflected a continuation of a pre-existing downward trajectory. The findings indicate that after accounting for these pre-existing factors, the association between mild to moderate acute kidney injury and worsening subsequent kidney function was small.
While the data suggest that mild to moderate acute kidney injury can act as an initiator or promoter of kidney disease progression, the researchers concluded that the actual magnitude of its clinical and public health importance is likely limited. For the practicing physician, these results clarify that a single episode of KDIGO Stage 1 or Stage 2 acute kidney injury does not typically necessitate a radical shift in long-term management strategies. Instead, the findings imply that a patient's long-term renal prognosis remains more heavily influenced by their baseline health and pre-injury filtration trends than by the acute event itself. This suggests that clinical focus should remain on managing chronic risk factors, such as hypertension and diabetes, rather than attributing significant long-term functional decline to a single, mild acute renal insult.
References
1. Hill NR, Fatoba S, Oke J, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS ONE. 2016. doi:10.1371/journal.pone.0158765
2. Gedfew M, Getie A, Akalu TY, Ayenew T. Prevalence and associated factors of acute kidney injury in Ethiopia, systematic review and meta-analysis.. Journal of nephrology. 2024. doi:10.1007/s40620-024-02115-2
3. Meersch M, Schmidt CG, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Medicine. 2017. doi:10.1007/s00134-016-4670-3
4. Guo J, Wei M, Zhang W, et al. Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials. Frontiers in Pharmacology. 2025. doi:10.3389/fphar.2025.1517272
5. Yuan C, Gao Y, Lin Y, et al. Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis.. American journal of nephrology. 2024. doi:10.1159/000534366